{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:42Z","timestamp":1793235102198,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.mehy.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T12:34:16Z","timestamp":1508502856000},"page":"176-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Artesunate-quercetin\/luteolin dual drug nanofacilitated synergistic treatment for malaria: A plausible approach to overcome artemisinin combination therapy resistance"],"prefix":"10.1016","volume":"109","author":[{"given":"Nethravathi","family":"Puttappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-7194","authenticated-orcid":false,"given":"Karthik","family":"Yamjala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.10.016_b0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.02.024","article-title":"Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo","volume":"34","author":"Sandra","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mehy.2017.10.016_b0010","unstructured":"World Malaria Report 2016. Geneva: World Health Organization; 2016. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"10.1016\/j.mehy.2017.10.016_b0015","unstructured":"Despommier, Gwadz, Hotez, Knirsch. Parasitic diseases 5th edition Apple tree production, LLC, Pub. Newyork. 50\u201368."},{"key":"10.1016\/j.mehy.2017.10.016_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.actatropica.2011.03.005","article-title":"Anti-malarial drug formulations and novel delivery systems: a review","volume":"118","author":"Musabayane","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.mehy.2017.10.016_b0025","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/ph3072322","article-title":"Artesunate: the best drug in the treatment of severe and complicated malaria","volume":"3","author":"Li","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.016_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1773-2247(14)50010-X","article-title":"Formulation of novel artesunate-loaded solid lipid microparticles (SLMs) based on dika wax matrices: in vitro and in vivo evaluation","volume":"24","author":"Chinaeke","year":"2014","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.mehy.2017.10.016_b0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00436-015-4747-x","article-title":"Phytochemical screening and in vivo antimalarial activity of extracts from three medicinal plants used in malaria treatment in Nigeria","volume":"115","author":"Bankole","year":"2016","journal-title":"Parasitol Res"},{"key":"10.1016\/j.mehy.2017.10.016_b0040","doi-asserted-by":"crossref","unstructured":"Alebie, Befkadu U, Amha WG. Systematic review on traditional medicinal plants used for the treatment of malaria in Ethiopia: trends and perspectives Malar J 2017;16(307);1\u201313.","DOI":"10.1186\/s12936-017-1953-2"},{"issue":"9","key":"10.1016\/j.mehy.2017.10.016_b0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2007-986916","article-title":"Modulation of the in vitro antimalarial effects of artemisinin by selected flavonoids and by reducing agents","volume":"73","author":"Sannella","year":"2007","journal-title":"Planta Med"},{"key":"10.1016\/j.mehy.2017.10.016_b0050","unstructured":"Barthelemy A, Latifou L, Dodehe Y, Cyril A, Marcel K, Bernard W et al., In Vitro antiplasmodial and antileishmanial activities of flavonoids from Anogeissus Leiocarpus (Combretaceae) Int J Pharm Sci Rev Res 2011;11(20):1\u20136."},{"issue":"1","key":"10.1016\/j.mehy.2017.10.016_b0055","first-page":"13","article-title":"Plant flavonoids as potential source of future antimalarial leads","volume":"8","author":"Mithun","year":"2017","journal-title":"Syst Rev Pharm"},{"issue":"22","key":"10.1016\/j.mehy.2017.10.016_b0060","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.phytochem.2004.08.050","article-title":"Anti-plasmodial flavonoids from the stem bark of Erythrina abyssinica","volume":"65","author":"Yenesew","year":"2004","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.016_b0065","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1186\/s40064-016-3267-1","article-title":"Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs","volume":"5","author":"Ravikumar","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.mehy.2017.10.016_b0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mehy.2016.02.022","article-title":"Plasmodium falciparum malaria: convergent evolutionary trajectories towards delayed clearance following artemisinin treatment","volume":"90","author":"Prapon","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2017.10.016_b0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Mallika","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.mehy.2017.10.016_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001984","article-title":"The Community as the patient in malaria-endemic areas: preempting drug resistance with multiple first-linetherapies","volume":"13","author":"Boni","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2017.10.016_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/femsre\/fuw037","article-title":"The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread","volume":"41","author":"Charles","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.mehy.2017.10.016_b0090","first-page":"1","author":"Artemisinin and artemisinin-based combination therapy resistance. Global Malaria Programme","year":"2016","journal-title":"Status Rep"},{"key":"10.1016\/j.mehy.2017.10.016_b0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-0500-1-26","article-title":"Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite","volume":"1","author":"Lehane","year":"2008","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.mehy.2017.10.016_b0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12936-015-0999-2","article-title":"In vitro and in vivo anti-malarial activity of plants from the Brazilian Amazon","volume":"14","author":"Renata","year":"2015","journal-title":"Malar J"},{"issue":"12","key":"10.1016\/j.mehy.2017.10.016_b0105","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.5012\/bkcs.2007.28.12.2495","article-title":"In vitro antimalarial activity of flavonoids and chalcones","volume":"28","author":"Soon","year":"2007","journal-title":"Bull Korean Chem Soc"},{"key":"10.1016\/j.mehy.2017.10.016_b0110","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1021\/jm0600545","article-title":"Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids","volume":"49","author":"Deniz","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.mehy.2017.10.016_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1574-6968.2006.00263.x","article-title":"Antiparasitic activity of \u00a3avonoids and iso\u00a3avones against Cryptosporidiumparvum and Encephalitozoon intestinalis","volume":"259","author":"Jan","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.mehy.2017.10.016_b0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Nereide","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2017.10.016_b0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Benedetta","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.mehy.2017.10.016_b0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Richard","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mehy.2017.10.016_b0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","article-title":"Drug-resistant malaria: the Era of ACT","volume":"12","author":"Jessica","year":"2010","journal-title":"Curr Infect Dis Rep"},{"issue":"8","key":"10.1016\/j.mehy.2017.10.016_b0140","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1007\/s00436-016-5080-8","article-title":"Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana","volume":"115","author":"Gustav","year":"2016","journal-title":"Parasitol Res"},{"key":"10.1016\/j.mehy.2017.10.016_b0145","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3390\/molecules15053135","article-title":"Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer","volume":"15","author":"Jorge","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.mehy.2017.10.016_b0150","first-page":"1999","article-title":"Antiplasmodial effects of a few selected natural flavonoids and their modulation of artemisinin activity","volume":"3","author":"Bilia","year":"2008","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.mehy.2017.10.016_b0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmcl.2014.11.039","article-title":"The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs","volume":"25","author":"Travis","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.mehy.2017.10.016_b0160","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin- the debate continues","volume":"15","author":"Paul","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.mehy.2017.10.016_b0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.03663-14","article-title":"Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species","volume":"59","author":"Gopalakrishnan","year":"2015","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1016\/j.mehy.2017.10.016_b0170","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","article-title":"Artemisinins target the SERCA of Plasmodium falciparum","volume":"424","author":"Eckstein","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mehy.2017.10.016_b0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.15698\/mic2016.05.498","article-title":"The molecular and cellular action properties of artemisinins: what has yeast told us?","volume":"3","author":"Chen","year":"2016","journal-title":"Microb Cell"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.016_b0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pt.2010.11.006","article-title":"Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets","volume":"27","author":"Xavier","year":"2011","journal-title":"Trends Parasitol"},{"issue":"4","key":"10.1016\/j.mehy.2017.10.016_b0185","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cell.2014.07.011","article-title":"Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate","volume":"158","author":"Andreas","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2017.10.016_b0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","article-title":"Health effects of quercetin: from antioxidant to nutraceutical","volume":"585","author":"Agnes","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2017.10.016_b0195","doi-asserted-by":"crossref","first-page":"474","DOI":"10.9734\/EJMP\/2013\/4644","article-title":"Screening and characterization of antimalarial heme polymerase inhibitors from garlic cloves","volume":"3","author":"Manu","year":"2013","journal-title":"Eur J Med Plants"},{"key":"10.1016\/j.mehy.2017.10.016_b0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","article-title":"The flavonoid quercetin in disease prevention and therapy: facts and fancies","volume":"83","author":"Maria","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2017.10.016_b0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-2004-827200","article-title":"Inhibiting activities of secondary metabolite of Phlomis Brunnneogaleata against parasitic protozoa and plasmodial enoyl-ACP reductase, a crucial enzyme in fatty acid biosynthesis","volume":"70","author":"Hasan","year":"2004","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.016_b0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11101-005-5297-0","article-title":"Fatty acid biosynthesis, a new approach in antimalarial natural product discovery","volume":"5","author":"Deniz","year":"2006","journal-title":"Phytochem Rev"},{"issue":"9","key":"10.1016\/j.mehy.2017.10.016_b0215","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/IJN.S62756","article-title":"Formulation of nanotized curcumin and demonstration of its antimalarial efficacy","volume":"20","author":"Ghosh","year":"2014","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.016_b0220","first-page":"932","article-title":"Preliminary formulation and characterization of solid lipid nanoparticles containing chloroquine and a P-glycoprotein inhibitor: influences of lipid-surfactant ratios","volume":"7","author":"Ifeanyi","year":"2015","journal-title":"J Chem Pharm Res"},{"key":"10.1016\/j.mehy.2017.10.016_b0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Nereide","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2017.10.016_b0230","doi-asserted-by":"crossref","unstructured":"Priyanka P, Shital S, Sulabha P, Shobhona S, Vandana P. Artemether-Lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency. Int J Pharm. doi: 10.1016\/j.ijpharm.2016.07.021.","DOI":"10.1016\/j.ijpharm.2016.07.021"},{"key":"10.1016\/j.mehy.2017.10.016_b0235","first-page":"1","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of arteether: pharmacokinetics, toxicity and antimalarial activity in mice","author":"Pankaj","year":"2014","journal-title":"RSC Adv"},{"key":"10.1016\/j.mehy.2017.10.016_b0240","first-page":"1","article-title":"Controversies with selfemulsifying drug delivery system from pharmacokinetic point of view","author":"Bappaditya","year":"2016","journal-title":"Drug Delivery"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717308794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717308794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T19:49:42Z","timestamp":1570218582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717308794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":48,"alternative-id":["S0306987717308794"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.10.016","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate-quercetin\/luteolin dual drug nanofacilitated synergistic treatment for malaria: A plausible approach to overcome artemisinin combination therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}